Insulet Profit Margin 2007-2018 | PODD

Current and historical gross margin, operating margin and net profit margin for Insulet (PODD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Insulet net profit margin as of December 31, 2018 is 0.58%.
Insulet Annual Profit Margins
Insulet Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.900B $0.564B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71